NewDrugs is the professional
magazin for decision makers in the laboratories of pharma companies
with their own research activities and for executives in biotech research
and service laboratories. As the official organ of the European Association
of Pharma Biotechnology (EAPB), New Drugs accompanies the breathtaking
progress of technological development in the pharmaceutical laboratory
and ensures the speedy transfer of know-how in the areas of genomics,
proteomics and laboratory automation.
Reports on innovative laboratory technologies, products and processes
which are paving the way and accelerating progress to
a new generation of medicines are rounded off by the latest business
bulletins, product reviews and company news.
A high standard of reporting is guaranteed by an scientific advisory
board of top-name scientists.
Scientific
Editor and Head of the Advisory Board:
|
Conrad J. Coester, Ph.D. |
|
Conrad Coester studied pharmacy
between 1992 and 1996 and finished 2000 his Ph.D. in Pharmaceutical
Technology at the University of Frankfurt (Germany) under
supervision of Prof. Dr. J. Kreuter in the area of colloidal
drug delivery systems. After working as a Postdoctoral Fellow
at the Faculty for Pharmacy, University of Alberta in Edmonton
(Canada) for 18 month he became in September 2002 head of
the research group nanoparticulate Drug Delivery Systems on
the position of a scientific assistant in Pharmaceutical Technology
at the University of Munich (Germany). From January 2003 he
was additionally appointed as adjunct Professor at the Faculty
for Pharmacy, University of Alberta in order to co-supervise
different graduate students in the field of colloidal drug
carrier systems. Aside his research work he is teaching different
lab and lecture courses in Pharmaceutical Technology and Biopharmaceutics
in the undergraduate program. Since 3 years Conrad Coester
is reviewer for several international journals and joined
the scientific advisory board of NewDrugs in 2002. His scientific
output comprises 10 primary scientific papers, 12 poster presentations
at international conferences, 14 international oral presentations
and 2 patents/patent applications.
Conrad.Coester@cup.uni-muenchen.de
|
Download
the
-document:
EAPB-Forum
1/2001
EAPB-Forum 2/2001
EAPB-Forum 3/2001
EAPB-Forum 4/2001
EAPB-Forum 1/2002
EAPB-Forum 2/2002
EAPB-Forum 3/2002
EAPB-Forum 4/2002
EAPB-Forum 5/2002
EAPB-Forum 6/2002
EAPB-Forum 7/2002
EAPB-Forum 8/2002
EAPB-Forum 1/2003
EAPB-Forum 2/2003
EAPB-Forum 3/2003
EAPB-Forum 4/2003
EAPB-Forum 6/2003
EAPB-Forum 2/2004
EAPB-Forum 1/2005
Editorial Board
order
NewDrugs:
a)
free with
EAPB-membership or
b) order NewDrugs by payment:
Subscription rates in Euro: Germany 120,- per year; all other countries
160,- per year.
Circulation: 8 issues per year. It is possible to unsubscribe at
any time.
|